Yang Seung-Yeob, Kim Dong Gyu, Chung Hyun-Tai, Paek Sun Ha, Park Jae Hyo, Han Dae Hee
Department of Neurosurgery, Dongguk University College of Medicine, Goyang, Gyeonggi-do, South Korea.
Acta Neurochir (Wien). 2009 Feb;151(2):113-24. doi: 10.1007/s00701-008-0173-5. Epub 2009 Feb 10.
Radiosurgery is an effective treatment option for patients with small to medium sized arteriovenous malformations. However, it is not generally accepted as an effective tool for larger (>14 cm(3)) arteriovenous malformations because of low obliteration rates. The authors assessed the applicability and effectiveness of radiosurgery for large arteriovenous malformations.
We performed a retrospective study of 46 consecutive patients with more than 14 ml of arteriovenous malformations who were treated with radiosurgery using a linear accelerator and gamma knife (GK). They were grouped according to their initial clinical presentation-17 presented with and 29 without haemorrhage. To assess the effect of embolization, these 46 patients were also regrouped into two subgroups-25 with and 21 without preradiosurgical embolization. Arteriovenous malformations found to have been incompletely obliterated after 3-year follow-up neuroimaging studies were re-treated using a GK.
The mean treatment volume was 29.5 ml (range, 14.0-65.0) and the mean marginal dose was 14.1 Gy (range, 10.0-20.0). The mean clinical follow-up periods after initial radiosurgery was 78.1 months (range, 34.0-166.4). Depending on the results of the angiography, 11 of 33 patients after the first radiosurgery and three of four patients after the second radiosurgery showed complete obliteration. Twenty patients received the second radiosurgery and their mean volume was significantly smaller than their initial volume (P = 0.017). The annual haemorrhage rate after radiosurgery was 2.9% in the haemorrhage group (mean follow-up 73.3 months) and 3.1% in the nonhaemorrhage group (mean follow-up 66.5 months) (P = 0.941). Preradiosurgical embolization increased the risk of haemorrhage for the nonhaemorrhage group (HR, 28.03; 95% CI, 1.08-6,759.64; P = 0.039), whereas it had no effect on the haemorrhage group. Latency period haemorrhage occurred in eight patients in the embolization group, but in no patient in the nonembolization group (P = 0.004).
Radiosurgery may be a safe and effective arteriovenous malformation treatment method that is worth considering as an alternative treatment option for a large arteriovenous malformation.
放射外科手术是治疗中小型动静脉畸形患者的一种有效治疗选择。然而,由于闭塞率低,它通常不被认为是治疗较大(>14 cm³)动静脉畸形的有效工具。作者评估了放射外科手术对大型动静脉畸形的适用性和有效性。
我们对46例连续的动静脉畸形体积超过14 ml且接受直线加速器和伽玛刀(GK)放射外科治疗的患者进行了回顾性研究。他们根据初始临床表现分组——17例有出血表现,29例无出血表现。为了评估栓塞的效果,这46例患者也被重新分为两个亚组——25例有放射外科手术前栓塞,21例无放射外科手术前栓塞。在3年的随访神经影像学研究后发现动静脉畸形未完全闭塞的患者,使用GK进行再次治疗。
平均治疗体积为29.5 ml(范围14.0 - 65.0),平均边缘剂量为14.1 Gy(范围10.0 - 20.0)。首次放射外科手术后的平均临床随访期为78.1个月(范围34.0 - 166.4)。根据血管造影结果,首次放射外科手术后33例患者中的11例以及第二次放射外科手术后4例患者中的3例显示完全闭塞。20例患者接受了第二次放射外科手术,其平均体积明显小于初始体积(P = 0.017)。放射外科手术后出血组的年出血率为2.9%(平均随访73.3个月),非出血组为3.1%(平均随访66.5个月)(P = 0.941)。放射外科手术前栓塞增加了非出血组的出血风险(风险比,28.03;95%可信区间,1.08 - 6,759.64;P = 0.039),而对出血组没有影响。栓塞组有8例患者发生延迟期出血,而非栓塞组无患者发生(P = 0.004)。
放射外科手术可能是一种安全有效的动静脉畸形治疗方法,值得作为大型动静脉畸形的替代治疗选择加以考虑。